Branca RM

Author Correction: Characterization of a second class Ie ribonucleotide reductase.

John J, Lundin D, Branca RM, ..., Lebrette H, Högbom M

Commun Biol 8 (1) 532 [2025-04-01; online 2025-04-01]

Characterization of a second class Ie ribonucleotide reductase.

John J, Lundin D, Branca RM, ..., Lebrette H, Högbom M

Commun Biol 8 (1) 281 [2025-02-22; online 2025-02-22]

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.

Manfredi F, Stasi L, Buonanno S, ..., Bonini C, Ruggiero E

Sci Adv 9 (48) eadg8014 [2023-12-00; online 2023-12-01]

Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors

Chiaro J, Antignani G, Feola S, ..., Lehtiö J, Cerullo V

- - (-) - [2022-11-08; online 2022-11-08]

Generation of ENSEMBL-based proteogenomics databases boosts the identification of non-canonical peptides

Umer HM, Zhu Y, Pfeuffer J, ..., Branca R, Perez-Riverol Y

- - (-) - [2021-06-09; online 2021-06-09]